Increased renal expression of nitric oxide synthase and atrial natriuretic peptide in rats with glycyrrhizic-acid-induced hypertension

Phytotherapy Research

Volumn 23, Issue 2, 2009, Pages 206-211

  Ma, Seong Kwon ^a   Bae, Eun Hui ^a   Kim, In Jin ^a   Choi, Ki Chul ^a   Kim, Suhn Hee ^b   Lee, Jongun ^a   Kim, Soo Wan ^a  

^a Chonnam National University   (South Korea)

^b Chonbuk National University   (South Korea)

Author keywords

Glycyrrhizic acid; Hypertension; Kidney; Mineralocorticoid receptor; Natriuretic peptide; Nitric oxide synthase

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCYRRHIZIC ACID; GUANYLATE CYCLASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR C; ATRIAL NATRIURETIC FACTOR RECEPTOR; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HYPERTENSION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SYSTOLIC BLOOD PRESSURE; ANIMAL; CHEMICALLY INDUCED DISORDER; GENE EXPRESSION; KIDNEY; METABOLISM; SPRAGUE DAWLEY RAT;

GLYCYRRHIZA; RATTUS;

ANIMALS; ATRIAL NATRIURETIC FACTOR; GENE EXPRESSION; GLYCYRRHIZIC ACID; HYPERTENSION; KIDNEY; MALE; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RECEPTORS, MINERALOCORTICOID;

EID: 59449093220     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2588     Document Type: Article

References (37)

1. Allcock GH, Hukkanen M, Polak JM, Pollock JS, Pollock DM. 1999. Increased nitric oxide synthase-3 expression in kidneys of deoxycorticosterone acetate-salt hypertensive rats. J Am Soc Nephrol 10: 2283-2289.
2. Bostanjoglo M, Reeves WB, Reilly RF, Velazquez H, Robertson N, Litwack G, Morsing P, Dorup J, Bachmann S, Ellison DH. 1998. 11Beta-hydroxysteroid dehydrogenase, mineralocorticoid receptor, and thiazide-sensitive Na-Cl cotransporter expression by distal tubules. J Am Soc Nephrol 9: 1347-1358.
3. Card WI, Mitchell W, Strong JA, Taylor NR, Tompsett SL, Wilson JM. 1953. Effects of liquorice and its derivatives on salt and water metabolism. Lancet 1: 663-668.
4. Davis EA, Morris DJ. 1991. Medicinal uses of licorice through the millennia: the good and plenty of it. Mol Cell Endocrinol 78: 1-6.
5. Edwards CR, Stewart PM, Burt D, Brett L, Mclntyre MA, Sutanto WS, de Kloet ER, Monder C. 1988. Localisation of 11 beta- hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 2: 986-989.
6. Funder JW, Pearce PT, Smith R, Smith Al. 1988. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242: 583-585.
7. Funder JW. 2005. Mineralocorticoid receptors: distribution and activation. Heart Fail Rev 10: 15-22.
8. Harris PJ, Thomas D, Morgan TO. 1987. Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption. Nature 326: 697-698.
9. Hobbs AJ. 1997. Soluble guanylate cyclase: the forgotten sibling. Trends Pharmacol Sci 18: 484-491.
10. John SW, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, Smithies O. 1995. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267: 679-681.
11. Kim SW, Lee J, Park JW, Hong JH, Kook H, Choi C, Choi KC. 2001. Increased expression of atrial natriuretic peptide in the kidney of rats with bilateral ureteral obstruction. Kidney Int 59: 1274-1282.
12. Lee J, Kim S, Jung M, Oh Y, Kim SW. 2002. Altered expression of vascular natriuretic peptide receptors in experimental hypertensive rats. Clin Exp Pharmacol Physiol 29: 299-303.
13. Lee J, Kim SW, Jung TK, Oh Y, Park CS, Ma SK, Kim NH, Choi KC. 2004. Indomethacin decreases particulate guanylyl cyclase activity in rat kidney. Clin Exp Pharmacol Physiol 31: 207-211.
14. Lee YJ, Shin SJ, Tan MS, Hsieh TJ, Tsai JH. 1996. Increased renal atrial natriuretic peptide synthesis in rats with deoxycorticosterone acetate-salt treatment. Am J Physiol 271: F779-F789.
15. Light DB, Schwiebert EM, Karlson KH, Stanton BA. 1989. Atrial natriuretic peptide inhibits a cation channel in renal inner medullary collecting duct cells. Science 243: 383-385.
16. T method. Methods 25: 402-408.
17. Ma SK, Nam Kl, Kim SW, Bae EH, Choi KC, Lee J. 2007. Increased renal expression of aquaporin-3 in rats inhibited type 2 11beta-hydroxysteroid dehydrogenase. Kidney Blood Press Res 30: 8-14.
18. Marin-Grez M, Fleming JT, Steinhausen M. 1986. Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney. Nature 324: 473-476.
19. Mattson DL, Maeda CY, Bachman TD, Cowley AW Jr. 1998. Inducible nitric oxide synthase and blood pressure. Hypertension 31: 15 -20.
20. Moncada S, Palmer RM, Higgs EA. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142.
21. Nakanishi K, Hara N, Nagai Y. 2002. Salt-sensitive hypertension in conscious rats induced by chronic nitric oxide blockade. Am J Hypertens 15: 150-156.
22. Nonoguchi H, Sands JM, Knepper MA. 1989. ANF inhibits NaCl and fluid absorption in cortical collecting duct of rat kidney. Am J Physiol 256: F179-F186.
23. Quaschning T, Ruschitzka F, Shaw S, Lüscher TF. 2001. Aldosterone receptor antagonism normalizes vascular function in liquorice- induced hypertension. Hypertension 37: 801-805.
24. Salom MG, Lahera V, Miranda-Guardiola F, Romero JC. 1992. Blockade of pressure natriuresis induced by inhibition of renal synthesis of nitric oxide in dogs. Am J Physiol 262: F718-F722.
25. Sigurjonsdottir HA, Axelson M, Johannsson G, Manhem K, Nyström E, Wallerstedt S. 2006. The liquorice effect on the RAAS differs between the genders. Blood Press 15: 169-172.
26. Sonnenberg H, Honrath U, Chong CK, Wilson DR. 1986. Atrial natriuretic factor inhibits sodium transport in medullary collecting duct. Am J Physiol 250: F963-F966.
27. Steinhelper ME, Cochrane KL, Field LJ. 1990. Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension 16: 301-307.
28. Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR. 1987. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 2: 821-824.
29. Stewart PM, Krozowski ZS. 1999. 11 beta-Hydroxysteroid dehydrogenase. Vitam Horm 57: 249-324.
30. Stockand JD, Sansom SC. 1997. Regulation of filtration rate by glomerular mesangial cells in health and diabetic renal disease. Am J Kidney Dis 29: 971-981.
31. Stoos BA, Garcia NH, Garvin JL. 1995. Nitric oxide inhibits sodium reabsorption in the isolated perfused cortical collecting duct. J Am Soc Nephrol 6: 89-94.
32. Tan DY, Meng S, Cason GW, Manning RD Jr. 2000. Mechanisms of salt-sensitive hypertension: role of inducible nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 279: R2297-R2303.
33. Tanahashi T, Mune T, Morita H, Tanahashi H, Isomura Y, Suwa T, Daido H, Gomez-Sanchez CE, Yasuda K. 2002. Glycyrrhizic acid suppresses type 2 11 beta-hydroxysteroid dehydrogenase expression in vivo. J Steroid Biochem Mol Biol 80: 441-447.
34. Torres VE, Hui YS, Shah SV, Northrup TE, Dousa TP. 1978. Cyclic nucleotide phosphodiesterases in glomeruli of rat renal cortex. Kidney Int 14: 444-451.
35. + and water channels in the collecting duct. Am J Transplant 5: 1276-1285.
36. Wilkins MR, Redondo J, Brown LA. 1997. The natriuretic-peptide family. Lancet 349: 1307-1310.
37. Winquist RJ, Faison EP, Waldman SA, Schwartz K, Murad F, Rapoport RM. 1984. Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle. Proc Natl Acad Sci USA 81: 7661-7664.